I. Introduction
During laparotomy, surgeons frequently experience difficult surgical conditions if the patient's abdominal wall or diaphragm is tense 1 . Saverse and Kitz 2 in 1975, described characteristics of an ideal muscle relaxant. The lack of cardiovascular effects of vecuronium established a benchmark for safety to which newer muscle relaxants are still held, so it still enjoys popularity in day to day practice 3. Stable neuromuscular blockade can be achieved rapidly with infusion of vecuronium and blockade can be quickly and easily antagonized following even prolong vecuronium infusion. Neuromuscular monitoring aids in assessing the relaxation during intubation, maintenance and reversal of anaesthesia. In 2010 clinical guidelines "When neuromuscular blocking drugs are given, the use of a peripheral nerve stimulator is recommended 5 .. Theoretical advantage of continuous infusion over intermittent bolus injection includes fewer period of poor anaesthesia control, a reduction in total amount of drug used and, more rapid recovery from anaesthesia 6, 7 . Delayed recovery and cumulation has been the impedance for continuous infusion of muscle relaxants.
Pharmacokinetics and pharmacodynamics of vecuronium is affected by multiple factors like age, sex, temperature etc. In our observation study, we have tried to quantify the dose of vecuronium needed by continuous infusion after a loading dose in elective abdominal surgeries, the time needed for recovery, the adequacy of relaxation, hemodynamics and complication if any during anesthesia.
II. Material And Methods
50 patients of ASA I and II physical status, between 18 to 65 years undergoing elective abdominal surgeries were enrolled in our prospective observational study after ethics committee approval. Patients with liver, kidney neurorneuromuscular disease, extensive malignancy and active foci of infections were excluded. History of intake of drug affecting neuromuscular blockade like aminoglycosides was ruled out.
Starvation and written informed consent noted. Peripheral nerve stimulator (the Neuromuscular monitoring device used was TOF Guard, Organonon Teknika. NV) was positioned on the ulnar nerve over the volar side of the wrist. visible TOF response was noted every 3 minutes intraoperatively. All patients were premedicated with intravenous Inj. diazepam 0.1 mg/kg and fentanyl 2 g/kg before induction. Induction was carried out with Inj. Thiopentone 4-6 mg/kg titrated . Supramaximal stimulus with single twitch was recorded. After confirming adequacy of ventilation, Inj. Succinylcholine 1.8 mg/kg was administered. Patient was intubated. Loading dose of Vecuronium 100 g/kg intravenously was given. Anesthesia was maintained with 2 between 32-37 mmHg). The neuromuscular monitoring was done throughout the surgery using a Peripheral Nerve Stimulator, and a. After recovery to TOF-1, an infusion of vecuronium was started using an infusion pump at the rate of 50 g/kg/hr and titrated at the rate of 5 g/kg/hr, to maintain a stable state of paralysis at TOF-1 during the surgery. After closure of the muscle layer and sheath, vecuronium infusion was stopped. With the return of TOF count 3, was done with Inj. Neostigmine 0.05 mg/kg and Inj. Glycopyrolate 8 g/kg.. Awakefulness, return of pharyngeal reflexes and adequate tone, patient was extubated after thorough oral suction and post-oxygenated for with 100% oxygen. Hemodynamics were monitored throughout the surgery. 20% rise from mean baseline of the preoperative values of heart rate and blood pressure will be considered as significant tachycardia and hypertension treated with additional dose of fentanyl 1 g/kg initially if untreated other modalities (inhalational agents, antihypertensives) were used and patient were discarded from the study.
The total dose of vecuronium infused was noted. The dose required for stable paralysis in g/kg/hr will be calculated. Recovery time, defined as time from termination of vecuronium infusion till appearance of TOF count of 3 was noted.The operating surgeon will judge the muscle relaxation in to adequate, good, poor depending upon the retraction required by them during the surgery. Statistical Analysis : Results were expressed as mean values + standard deviation. P values for mean values were calculated using Student's 't' test. Pearson's correlation coefficient were calculated wherever applicable. Results were considered statistically significant at the 'p' at 0.05 level.
III. Results
The mean age of patients study was 46.22 + 9.37 years. 5 patients were above 60 years. 38 females and 12 males in the study and not comparable. The heart rate and bloodpressure was monitored every 5 min. The mean change from the preinduction values were studied. There was mean change of 3 + 3.84/minute from the preinduction heart rate, the mean preinduction heart rate was 68.94 + 7.07/minute and the mean intraoperative heart rate was 71.94 + 6.93/minute.The mean preinduction systolic blood pressure was 131.72 + 8.45 mmHg while the mean intraoperative systolic blood pressure was 136.37+9.22 mmHg and the mean difference was 4.66 + 5.43 mmHg. The mean preinduction diastolic blood pressure was 79.58 + 5.43 mmHg while the mean intraoperative diastolic blood pressure was 82.21 + 5.10 mmHg with a mean change of 2.54 + 3.68 mmHg. There was increase in the heart rate, systolic blood pressure, and diastolic blood pressure at intubation and initial period of starting infusion and latter the vitals paralleled the preinduction values. The p values are calculated in comparison with the preinduction values, @ p value < 0.05 significant. The significant difference cannot be calculated at 150 and 165 minutes of infusion as sample size was one. The variability the data at 150 and 165 minutes may be due to thinning of the sample size. . p valve of heart rate from 15 minutes from starting of infusion is p = 0. There is significant difference during intubation, TOF-1, and reversal in heart rate, systolic blood pressure and diastolic blood pressure. There is no is significant difference during vecuronium infusion in the heart rate in comparison with the preinduction heart rate. There is significant difference in systolic blood pressure and diastolic blood pressure at 15 minutes from starting of vecuronium infusion. The variability in heart rate, systolic blood pressure and diastolic blood pressure becomes insignificant from 30 minutes till end of infusion. The mean recovery time was 12.4  3.63 minutes. The minimum time of spontaneous recovery was 7 minutes and the maximum time was 28 minutes. The maximum 30% patients fall in range of 5-11 minutes and 54% are in 11-15 minutes (Figure- 
IV. Discussion
Use of muscle relaxants not only revolutionized the practice of anesthesia but also started the modern era of surgery and made possible the explosive development of cardiothoracic, neurologic and organ transplant surgery, as stated by Foldes and co-authors 8 . Vecuronium is an intermediate-acting drug with an onset time of 2-3 minutes acting for around 22 + 2 minutes. Efficient titration by continuous infusion will lead to use of lesser drug, will maintain stable paralysis state, minimize the adverse effects and allow a rapid recovery on termination of the drug. The only drawback is cumulative effect in prolonged infusion of drug if given in large doses. Eriksson LI, et al 9 and Mirakhur RK, et al 10 showed no cumulation occurs with vecuronium. that prompt recovery occurs without any cumulative effect 50 Patients between 18-65 years were selected, the dose requirement of vecuronium varies with the age group. Figure-1 11 in their age dependant dose response relationship study noted requirement of vecuronium for age groups were as follows,The vecuronium requirement in our study ( Figure-1 ) in age groups < 40 years and 40-60 years parallels the results in d'Hollander study. The dose needed in age group > 60 years is less than patients of < 60 years in both studies. Cynthia A Lien, et al 12 concluded that an anesthetist should expect the action of vecuronium to be prolonged in elderly surgical patients
The mean maintenance dose given by infusion to maintain a stable paralysis in our study was 62.79 + 5.63 g/kg/hr (Figure-1 15 showed that for 90% reduction of twitch force, dose required is 47.6 + 9.7 g/kg/hr. Halothane + Fentanyl (3-8 g/kg) was used for maintenance.
Cannon JE, et al [4] noted the dose of vecuronium infusion with inhalational anesthetic agents and compared with fentanyl anesthesia. This concludes that dose required of vecuronium is decreased with inhalational agents. Hence, no volatile anesthetic agent was used in our study.There was no correlation with the dose of infusion of vecuronium required to maintain a stable paralysis and the time of recovery in the study, (p=0.386) . In our study, the vecuronium infusion was started at TOF response of one. The mean duration to reach TOF of 1 was 23.74 + 5.82 minutes. Christoph Diefenbach, et al 16 , noted that the time of recovery from initial dose to 25% of the twitch control was 36 + 11 min with fentanyl, midazolam and etomidate anesthesia. While W Buzello and G Noldge 2 noted (dur 25%) 26 minutes in with N 2 O + O 2 + Fentanyl anesthesia, where Vecuronium was given by continuous infusion for 201 minutes.
The heart rate and SBP/DBP showed mean rise of 3.00 + 3.84/minute and 4.66 + 5.43mmHg/2.53 + 3.68 mmHg from preinduction value respectively. , Chaudhari LS, et al 13 showed a mean change of 5.99 + 2.67% and fall in blood pressure by 3.46 + 3.35% from the baseline value .(Pentazocin and atracurium based anesthesia) from the preinduction baselines values. The initial increase in heart rate and blood pressure correlates with the intubation response and TOF-1 (Figure-2,3) is noted resulting in lighter planes of relaxation and a need for additional drug to maintain the depth of paralysis. Gradually the heart rate and blood pressure (Figure-2,3 ) reached near the preinduction levels, once the infusion was started and stabilized to maintain a constant single TOF response. After stopping of infusion and during reversal again a rise in vital parameters were noted. Throughout our study, the heart rate did not decrease more than 20% from the preinduction value. As opposed to our study, EN Robertson, et al 17 noted a statically significant drop in heart rate at 5 and 10 minutes after administration of vecuronium
The p value of systolic (p = 0.00) and diastolic (p = 0.12), blood pressure at 15 minutes after starting of infusion showed a significant difference from the preinduction values, while no significant difference is noted in heart rate (p = 0.12) of the patients( figure-2,3) . Fentanyl is known to decrease the heart rate, in our study fentanyl was given to patients every 40 minutes, so the heart rate showed less rise as compared to blood pressure in the study. Wiedra JMKH 18 in a study of 320 patients showed that vecuronium did not influence heart rate and systolic blood pressure. Starting vecuronium infusion near to loading dose may decrease the initial hemodynamic instability. The mean spontaneous recovery time to recover from TOF of 1 to 3 was 12.4 + 3.63 minutes (Figure-4) . 54% patients showed a recovery time between 11-15 minutes . Figure-5 )and it is significant as p > 0.05 (i.e. 0.02), (Figure-5 ). The recovery time was 19 minutes in 57 years male patient received infusion for 145 minutes, while 18 minutes in 45 years female where infusion was given for 145 minutes increases if the infusion is given for longer duration, which is often noticed in ICU set-up. In the study done by Prielipp RC, et al 20 , recovery time averaged 387 + 163 minutes where 30 patients received vecuronium infusion for mean duration of 66 + 12 hours in ICU.WS Beattie, et al 21 predicted that vecuronium induced blockade would be reversed faster in procedures lasting less than three hours or in young patients and also gave an equation for vecuronium reversal (time in minutes) = -7.25 + 0.284 (age in years) + 0.12 (duration).
In our study, the longest recovery period of 28 minutes was seen in a patient who was over weight (88 kg) and elderly (64 years) as well. AE Schwartz, et al 22 proved that time to recovery from neuromuscular blockade was longer in obese patients (93.4 + 13.9 kg) as opposed to non-obese patients (60.9 + 12.3 kg).Cynthia A Lien, et al 23 and De Almeida Mc, et al 24 concluded that an anesthetist should expect the action of vecuronium to be prolonged in elderly surgical patients. The altered pharmacokinetics and age related changes in renal and hepatic function prolonged the recovery time.
The quality of relaxation was judged by surgical the team ( Table-6 ). It was a subjective assessment with lots of individual variability. Twenty-seven patients (54%) had a good relaxation, while adequate was seen in 20 (40%) patients. Only in 3 patients (6%) the relaxation was poor. Patients were then monitored in PostAnesthesia Care Unit and after confirming normal hemodynamic status and adequate muscle tone, patients were shifted to respective wards. All patients were stable hemodynamically Fawcett W, et al 25 found that the postoperative recurarisation was 24% in vecuronium infusion group as compared to bolus group it was it was 12%. However, in their study difference could not be made clinically in the two groups. Figures  Fig-1 Mean Dose in g/kg /hr of Vecuronium given by continuous Infusion in respective age groups 
V. Conclusion
So we conclude that the vecuronium by continuous infusion technique provides an adequate level of relaxation, hemodynamic stability and prompt recovery without any side effects. The future prospective to the study would be computerized drug delivery system permitting self adjustment of the rate of infusion with respect to the TOF response. The better way of administrating short to intermediate acting muscle relaxants would be computerized analysis of patient's plasma concentration of the drug and auto-adjustment of the infusion rate accordingly, by the system.
